1. Prognostic significance of several biomarkers in epithelial ovarian cancer: a meta-analysis of published studies

   • Linjuan Xu
   • Jing Cai
   • Zehua Wang

   Review 18 April 2013 Pages: 1257 - 1277

   

2. Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor

   • Seon-Hyeong Lee
   • Nayeon Kim
   • Soo-Youl Kim

   Original Paper 21 April 2013 Pages: 1279 - 1294

   

3. High IL-17-positive tumor immune cell infiltration is indicative for chemosensitivity of ovarian carcinoma

   • Raoul A. Droeser
   • Uwe Güth
   • Gad Singer

   Original Paper 28 April 2013 Pages: 1295 - 1302

   

4. Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients

   • Francesca Bella
   • Pamela Minicozzi
   • Milena Sant

   Original Paper 30 April 2013 Pages: 1303 - 1310

   

5. Prognostic impact of LDH levels in patients with relapsed/refractory seminoma

   • Tom Powles
   • Caroline Bascoul-Mollevi
   • Jörg Beyer

   Original Paper 03 May 2013 Pages: 1311 - 1316

   

6. Liver resection in selected patients with metastatic breast cancer: a single-centre analysis and review of literature

   • Y. Dittmar
   • A. Altendorf-Hofmann
   • U. Settmacher

   Original Paper 04 May 2013 Pages: 1317 - 1325

   

7. EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells

   • Giulia M. Stella
   • Roberta Scabini
   • Michele Zorzetto

   Original Paper 05 May 2013 Pages: 1327 - 1335

   

8. The Austrian experience with trabectedin in non-selected patients with metastatic soft tissue sarcoma (STS)

   • F. Ploner
   • W. Lamm
   • T. Brodowicz

   Original Paper 11 May 2013 Pages: 1337 - 1342

9. Transarterial chemoembolization for pain relief in patients with hypervascular painful metastatic spinal tumors refractory to percutaneous vertebroplasty

   • Yi Chen
   • Zhiping Yan
   • Jianjun Luo

   Original Paper 16 May 2013 Pages: 1343 - 1348

   

10. Tuberin and p27 expression in breast cancer patients with or without BRCA germline mutations

    • Anne Catharina Dressler
    • Gernot Hudelist
    • Christian F. Singer

    Original Paper 21 May 2013 Pages: 1349 - 1355

    

11. Tandem therapy for retinoblastoma: immunotherapy and chemotherapy enhance cytotoxicity on retinoblastoma by increasing apoptosis

    • Qiuling Liu
    • Yafeng Wang
    • Patricia Elena Kunda

    Original Paper 21 May 2013 Pages: 1357 - 1372

    

12. Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival

    • Ferhat Ozden
    • Caner Saygin
    • Hilal Aki

    Original Paper 25 May 2013 Pages: 1373 - 1382

    

13. Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy

    • Kohei Shitara
    • Keitaro Matsuo
    • Atsushi Ohtsu

    Original Paper 25 May 2013 Pages: 1383 - 1389

    

14. EGFR L2 domain mutation is not correlated with resistance to cetuximab in metastatic colorectal cancer patients

    • Yuriko Ito
    • Yasuhide Yamada
    • Yasuhiro Shimada

    Original Paper 31 May 2013 Pages: 1391 - 1396

    

15. Lack of association of platelet-derived growth factor (PDGF) receptor autoantibodies and severity of chronic graft-versus-host disease (GvHD)

    • Baerbel Spies-Weisshart
    • Kristina Schilling
    • Sebastian Scholl

    Original Paper 01 June 2013 Pages: 1397 - 1404

    

16. Association between genetic variants in pre-miRNA and colorectal cancer risk in a Chinese population

    • Meili Lv
    • Wei Dong
    • Lin Zhang

    Original Paper 02 June 2013 Pages: 1405 - 1410

17. Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff?

    • P. Gazzaniga
    • C. Raimondi
    • E. Cortesi

    Original Paper 05 June 2013 Pages: 1411 - 1416

    

18. A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis

    • Cheng Xu
    • Zhehui Yan
    • Yuming Wang

    Original Paper 07 June 2013 Pages: 1417 - 1424

    

19. Cilengitide response in ultra-low passage glioblastoma cell lines: relation to molecular markers

    • Christina S. Mullins
    • Julia Schubert
    • Carl F. Classen

    Original Paper 08 June 2013 Pages: 1425 - 1431